In colorectal and rectal cancer care, targeted drugs are sometimes added to standard chemotherapy. With one group of these drugs called EGFR inhibitors (such as cetuximab or panitumumab), many people notice an acne-like red rash (acneiform rash) on the face, scalp, chest, and back within the first one to three weeks, followed over time by markedly dry skin (xerosis).
These changes are not a sign of poor hygiene. The pathway this medicine targets (EGFR) is also present in the skin and hair follicles, so the rash and dryness are linked to how the drug works. For this reason, ordinary acne products that strongly dry or exfoliate the skin can actually irritate it and make dryness worse.
Helpful everyday habits are fairly consistent. Wash briefly with lukewarm water, and avoid heavily scented or alcohol-rich products. Applying moisturizer generously while the skin is still slightly damp can ease dryness and itching. Sunlight can make the rash more prominent, so use sunscreen and cover up with a hat and long sleeves when going outdoors. Avoid scratching or squeezing the rash, since this can lead to scarring or secondary infection.
Importantly, if the rash or dryness becomes severe, do not stop the medication on your own — talk with your care team first. Depending on severity, they may recommend topical or oral antibiotics and moisturizing ointments, or adjust the dose. Yellow discharge, crusting, pain, or fever around the rash may signal infection and should be reported promptly. In some patients this skin reaction is viewed as a possible clue that the drug is working, but this varies from person to person, so it should be assessed together with your medical team rather than judged on your own.
This article is for general information only and does not replace personal diagnosis or treatment. Please discuss management suited to your specific medication and symptoms with your healthcare provider.